Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1088 | 1088 | 1181 | 1301 | 1678 | 2947 |
Fund Return | 8.85% | 8.85% | 18.07% | 9.17% | 10.91% | 11.41% |
Place in category | 4374 | 4374 | 4208 | 1993 | 1516 | 471 |
% in Category | 62 | 62 | 67 | 40 | 41 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fundc | 13.33B | 8.02 | 4.73 | 10.38 | ||
Capital Group New Perspective Funzc | 13.33B | 7.97 | 4.46 | 10.18 | ||
Capital Group New Perspective Fuzdc | 13.33B | 7.96 | 4.46 | 10.18 | ||
Capital Group New Perspective Fubc | 13.33B | 7.73 | 3.68 | 9.31 | ||
Capital Group Global Allocation zdc | 1.26B | 6.15 | 4.92 | 7.65 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 8.71B | 6.72 | 8.43 | - | ||
Swisscanto CH IPF I Index Equity Fu | 6.01B | 10.60 | 8.37 | 9.76 | ||
CH0337393745 | 6.26B | 7.41 | 8.69 | - | ||
UBS CH Institutional Fund 2 EquiPAX | 4.48B | 16.91 | 7.54 | 10.23 | ||
Swisscanto CH IPF III Index EquAST | 3.26B | 10.63 | 7.97 | 9.33 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.05 | 871.3 | +0.44% | |
Broadcom | US11135F1012 | 2.84 | 1,282.63 | -3.49% | |
Microsoft | US5949181045 | 2.44 | 411.84 | -0.66% | |
ASML Holding | NL0010273215 | 2.15 | 852.40 | -6.68% | |
Safran | FR0000073272 | 2.14 | 206.70 | +0.83% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review